{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:44:57Z","timestamp":1788245097464,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Heidelberg university"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Hepatic chemosaturation for inoperable liver tumors is a palliative treatment option with a beneficial effect on survival. However, the procedure regularly leads to circulatory failure during the filtration phase, and hemodynamic management is challenging. Our study aimed to compare two different strategies for hemodynamic management during chemosaturation to develop hypotheses for improving patient care and reducing peri-interventional morbidity. Methods: We conducted a single-center retrospective cohort study including 66 procedures of chemosaturation between May 2016 and March 2024. Procedures were divided into two groups: group 1 was managed with norepinephrine as the only vasopressor and liberal use of hydroxyethyl starch (HES). Group 2 was managed with norepinephrine and vasopressin and the preferred use of balanced crystalloids. We compared these two groups with respect to hemodynamic parameters, laboratory values, and post-interventional complications.\u00a0Results: The heart rate was highest and the mean arterial pressure (MAP) was lowest during the filtration phase in both groups (p = 0.868, p = 0.270). The vasoactive inotropic score (VIS) was significantly higher in group 2 during the filtration phase (31.5 vs. 89, p &lt; 0.001). Group 1 received significantly more HES overall (1000 mL vs. 0 mL, p &lt; 0.001). Lactate levels at admission to the ICU were higher in group 1 (22.9 vs. 14.45 mg\/dL, p = 0.041). Platelet counts were lower in group 2 from directly after chemosaturation through day 2 (p = 0.022, p = 0.001, p = 0.032). The INR differed significantly directly after chemosaturation (1.13 vs. 1.26, p = 0.015). Overall, group 1 received significantly more blood products peri-interventionally. There were two bleedings and one ischemic stroke in the overall cohort. There was no peri-interventional mortality. Conclusions: Advanced hemodynamic management ensures low peri-interventional mortality and morbidity. High-dose vasopressors, including vasopressin and the preferred use of balanced crystalloids, are sufficient to stabilize circulatory function during chemosaturation.<\/jats:p>","DOI":"10.3390\/cancers16213698","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T04:59:54Z","timestamp":1730437194000},"page":"3698","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Peri-Interventional Hemodynamic Management Strategies for Percutaneous Chemosaturation of the Liver in Metastatic Cancer"],"prefix":"10.3390","volume":"16","author":[{"given":"Patrick","family":"Rehn","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"},{"name":"Department of Pediatric Cardiology and Congenital Heart Diseases, Center for Child and Adolescent Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1452-625X","authenticated-orcid":false,"given":"Jan","family":"Turra","sequence":"additional","affiliation":[{"name":"Department of Perfusion, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Adler","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1957-1594","authenticated-orcid":false,"given":"Philipp","family":"Mayer","sequence":"additional","affiliation":[{"name":"Department of Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2086-0107","authenticated-orcid":false,"given":"Dania","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0127-2783","authenticated-orcid":false,"given":"Mascha O.","family":"Fiedler-Kalenka","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6464-6191","authenticated-orcid":false,"given":"Felix C. F.","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Hua","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"},{"name":"Department of Radiology, Cantonal Hospital of Lucerne, 6000 Lucerne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lichtenstern","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6962-037X","authenticated-orcid":false,"given":"Mark O.","family":"Wielp\u00fctz","sequence":"additional","affiliation":[{"name":"Department of Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"},{"name":"Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Im Neuenheimer Feld 130.3, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"Kauczor","sequence":"additional","affiliation":[{"name":"Department of Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"},{"name":"Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Im Neuenheimer Feld 130.3, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Weigand","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0960-038X","authenticated-orcid":false,"given":"Maximilian","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.6004\/jnccn.2018.0042","article-title":"New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma","volume":"16","author":"Barker","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1007\/s12325-016-0424-4","article-title":"Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review","volume":"33","author":"Vogel","year":"2017","journal-title":"Adv. Ther."},{"key":"ref_3","first-page":"928","article-title":"Chemosaturation durch perkutane hepatische Perfusion mit Melphalan bei hepatisch metastasiertem Aderhautmelanom: Eine \u00dcberlebens- und Sicherheitsanalyse","volume":"193","author":"Dewald","year":"2021","journal-title":"R\u00f6Fo-Fortschritte Auf Dem Geb. Der R\u00f6ntgenstrahlen Und Der Bildgeb. Verfahr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.sla.0000103133.03688.3d","article-title":"Reductive surgery plus percutaneous isolated hepatic perfusion for multiple advanced hepatocellular carcinoma","volume":"239","author":"Ku","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"102501","DOI":"10.1016\/j.ctrv.2022.102501","article-title":"Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence","volume":"113","author":"Vogel","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Dewald, C.L.A., Warnke, M.-M., Br\u00fcning, R., Schneider, M.A., Wohlmuth, P., Hinrichs, J.B., Saborowski, A., Vogel, A., and Wacker, F.K. (2021). Percutaneous Hepatic Perfusion (PHP) with Melphalan in Liver-Dominant Metastatic Uveal Melanoma: The German Experience. Cancers, 14.","DOI":"10.3390\/cancers14010118"},{"key":"ref_7","first-page":"1539","article-title":"Increased local cytostatic drug exposure by isolated hepatic perfusion: A phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver","volume":"82","author":"Vahrmeijer","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/annonc\/mdn032","article-title":"Isolated hepatic melphalan perfusion of colorectal liver metastases: Outcome and prognostic factors in 154 patients","volume":"19","author":"Gelderblom","year":"2008","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_9","first-page":"1557","article-title":"Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study","volume":"40","author":"Leede","year":"2014","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10585-022-10193-4","article-title":"New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option","volume":"40","author":"Dewald","year":"2023","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1213\/XAA.0000000000000496","article-title":"Percutaneous Isolated Hepatic Perfusion: Hemodynamic Monitoring and Goal-Directed Anesthetic Management: A Case Report","volume":"8","author":"Rodriguez","year":"2017","journal-title":"A A Case Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Struck, M.F., Kliem, P., Ebel, S., Bauer, A., G\u00f6ssmann, H., Veelken, R., van B\u00f6mmel, F., Dennecke, T., Stehr, S.N., and Girrbach, F.F. (2021). Percutaneous hepatic melphalan perfusion: Single center experience of procedural characteristics, hemodynamic response, complications, and postoperative recovery. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0254817"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00101-022-01235-3","article-title":"An\u00e4sthesiologisches und postinterventionelles Management bei perkutaner hepatischer Melphalanperfusion (Chemosaturation)","volume":"72","author":"Kliem","year":"2023","journal-title":"Die Anaesthesiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/1091581818811306","article-title":"Percutaneous Hepatic Perfusion With Filtered Melphalan for Localized Treatment of Metastatic Hepatic Disease: A Risk Assessment","volume":"37","author":"McEwan","year":"2018","journal-title":"Int. J. Toxicol."},{"key":"ref_15","first-page":"234","article-title":"Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass","volume":"11","author":"Gaies","year":"2010","journal-title":"Pediatr. Crit. Care Med. A J. Soc. Crit. Care Med. World Fed. Pediatr. Intensive Crit. Care Soc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1053\/j.jvca.2020.09.117","article-title":"Vasoactive-Inotropic Score: Evolution, Clinical Utility, and Pitfalls","volume":"35","author":"Belletti","year":"2021","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bja.2022.05.002","article-title":"Fluids, vasopressors, and acute kidney injury after major abdominal surgery between 2015 and 2019: A multicentre retrospective analysis","volume":"129","author":"Chiu","year":"2022","journal-title":"Br. J. Anaesth."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00003246-199201000-00020","article-title":"Lactic acidosis in critical illness","volume":"20","author":"Mizock","year":"1992","journal-title":"Crit. Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MCC.0000000000000423","article-title":"Lactate and microcirculation as suitable targets for hemodynamic optimization in resuscitation of circulatory shock","volume":"23","author":"Kiyatkin","year":"2017","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1378\/chest.12-0878","article-title":"Whole blood lactate kinetics in patients undergoing quantitative resuscitation for severe sepsis and septic shock","volume":"143","author":"Puskarich","year":"2013","journal-title":"Chest"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jama.2019.0071","article-title":"Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial","volume":"321","author":"Damiani","year":"2019","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s13054-020-03083-2","article-title":"Hypertonic sodium lactate improves microcirculation, cardiac function, and inflammation in a rat model of sepsis","volume":"24","author":"Besnier","year":"2020","journal-title":"Crit. Care"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1177\/0885066620982585","article-title":"Macrocirculatory and Microcirculatory Endpoints in Sepsis Resuscitation","volume":"36","author":"Mok","year":"2021","journal-title":"J. Intensive Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/trf.15311","article-title":"A consensus redefinition of transfusion-related acute lung injury","volume":"59","author":"Vlaar","year":"2019","journal-title":"Transfusion"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100891","DOI":"10.1016\/j.blre.2021.100891","article-title":"The recipe for TACO: A narrative review on the pathophysiology and potential mitigation strategies of transfusion-associated circulatory overload","volume":"52","author":"Bulle","year":"2022","journal-title":"Blood Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1378\/chest.120.3.989","article-title":"Physiology of vasopressin relevant to management of septic shock","volume":"120","author":"Holmes","year":"2001","journal-title":"Chest"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0049-3848(87)90252-0","article-title":"Mechanism of vasopressin-induced platelet aggregation","volume":"45","author":"Filep","year":"1987","journal-title":"Thromb. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/OPTH.S89591","article-title":"Uveal melanoma: Epidemiology, etiology, and treatment of primary disease","volume":"11","author":"Krantz","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00417-021-05317-7","article-title":"The epidemiology of uveal melanoma in Germany: A nationwide report of incidence and survival between 2009 and 2015","volume":"260","author":"Alfaar","year":"2022","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/21\/3698\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:26:25Z","timestamp":1760113585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/21\/3698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":30,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["cancers16213698"],"URL":"https:\/\/doi.org\/10.3390\/cancers16213698","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}